Elevated levels of PHGDH expression have been observed in various solid tumors, including triple-negative breast cancer, melanoma, and lung adenocarcinoma, and inhibiting this enzyme has demonstrated the ability to impede cancer cell proliferation (39–43). The gene discussed is PHGDH; the disease is triple-negative breast carcinoma.